Cypress Capital Group Has $711,000 Holdings in Danaher Corporation $DHR

Cypress Capital Group decreased its position in shares of Danaher Corporation (NYSE:DHR) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,600 shares of the conglomerate’s stock after selling 100 shares during the quarter. Cypress Capital Group’s holdings in Danaher were worth $711,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of DHR. Allspring Global Investments Holdings LLC raised its holdings in Danaher by 579.2% during the second quarter. Allspring Global Investments Holdings LLC now owns 375,863 shares of the conglomerate’s stock worth $75,586,000 after buying an additional 320,521 shares during the last quarter. Index Fund Advisors Inc. acquired a new stake in shares of Danaher in the 2nd quarter worth about $453,000. Acorn Creek Capital LLC lifted its position in Danaher by 67.6% in the 2nd quarter. Acorn Creek Capital LLC now owns 3,273 shares of the conglomerate’s stock valued at $646,000 after acquiring an additional 1,320 shares in the last quarter. LRI Investments LLC boosted its stake in Danaher by 2.3% during the 2nd quarter. LRI Investments LLC now owns 4,354 shares of the conglomerate’s stock valued at $860,000 after purchasing an additional 96 shares during the last quarter. Finally, CWM LLC increased its holdings in Danaher by 19.9% during the 2nd quarter. CWM LLC now owns 36,941 shares of the conglomerate’s stock worth $7,297,000 after purchasing an additional 6,130 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on DHR. Barclays restated an “overweight” rating and issued a $225.00 target price (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a report on Tuesday, September 2nd. Evercore ISI increased their target price on shares of Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Finally, Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $244.60.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Price Performance

DHR opened at $202.53 on Monday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The firm has a 50-day moving average of $200.66 and a 200 day moving average of $197.07. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm has a market cap of $145.02 billion, a P/E ratio of 43.09, a PEG ratio of 2.88 and a beta of 0.77.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period in the previous year, the company earned $1.72 earnings per share. The company’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.